Ramesh Hariharan
Corporate Officer/Principal bei NATERA, INC.
Profil
Ramesh Hariharan is currently working as the General Manager-Women's Health at Natera, Inc. Previously, he worked as the Vice President-Marketing at Biotheranostics, Inc. from 2014 to 2016.
Dr. Hariharan holds a doctorate degree from Princeton University, an undergraduate degree from the Indian Institute of Technology Bombay, and an MBA from Mit Solan School of Management.
Aktive Positionen von Ramesh Hariharan
| Unternehmen | Position | Beginn |
|---|---|---|
| NATERA, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ramesh Hariharan
| Unternehmen | Position | Ende |
|---|---|---|
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Vertrieb & Marketing | 01.04.2016 |
Ausbildung von Ramesh Hariharan
| Indian Institute of Technology Bombay | Undergraduate Degree |
| Princeton University | Doctorate Degree |
| Mit Solan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
